Leo F. Buckley

4.4k total citations · 1 hit paper
91 papers, 2.4k citations indexed

About

Leo F. Buckley is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Leo F. Buckley has authored 91 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Leo F. Buckley's work include Cardiovascular Function and Risk Factors (18 papers), Heart Failure Treatment and Management (18 papers) and Cardiovascular and exercise physiology (13 papers). Leo F. Buckley is often cited by papers focused on Cardiovascular Function and Risk Factors (18 papers), Heart Failure Treatment and Management (18 papers) and Cardiovascular and exercise physiology (13 papers). Leo F. Buckley collaborates with scholars based in United States, Italy and Saudi Arabia. Leo F. Buckley's co-authors include Antonio Abbate, Dave L. Dixon, Benjamín W. Van Tassell, Salvatore Carbone, Giuseppe Biondi‐Zoccai, Cory R. Trankle, John Fanikos, Benjamín Van Tassell, Stefano Toldo and Justin M. Canada and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Leo F. Buckley

89 papers receiving 2.4k citations

Hit Papers

Targeting the NLRP3 inflammasome in cardiovascular diseases 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo F. Buckley United States 27 1.2k 644 536 374 260 91 2.4k
Massimo R. Mannarino Italy 31 873 0.7× 458 0.7× 648 1.2× 361 1.0× 288 1.1× 77 2.6k
Xiao‐Mei Li China 25 629 0.5× 446 0.7× 485 0.9× 345 0.9× 174 0.7× 165 2.0k
Paolo Poggio Italy 29 1.2k 1.0× 659 1.0× 582 1.1× 364 1.0× 276 1.1× 102 2.8k
Mahir Karakas Germany 28 1.0k 0.8× 1.1k 1.6× 863 1.6× 361 1.0× 372 1.4× 94 3.3k
Amy K. Saenger United States 28 1.2k 0.9× 457 0.7× 721 1.3× 287 0.8× 150 0.6× 99 2.8k
Felice Gragnano Italy 28 1.0k 0.8× 285 0.4× 644 1.2× 432 1.2× 154 0.6× 114 2.0k
Wen‐Ter Lai Taiwan 26 1.6k 1.3× 319 0.5× 690 1.3× 285 0.8× 150 0.6× 229 2.6k
Danish Saleheen Pakistan 22 782 0.6× 410 0.6× 796 1.5× 561 1.5× 297 1.1× 45 2.4k
François Roubille France 27 1.4k 1.2× 523 0.8× 520 1.0× 109 0.3× 262 1.0× 215 2.9k
Tomonori Itoh Japan 21 755 0.6× 541 0.8× 574 1.1× 217 0.6× 267 1.0× 101 2.0k

Countries citing papers authored by Leo F. Buckley

Since Specialization
Citations

This map shows the geographic impact of Leo F. Buckley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo F. Buckley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo F. Buckley more than expected).

Fields of papers citing papers by Leo F. Buckley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo F. Buckley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo F. Buckley. The network helps show where Leo F. Buckley may publish in the future.

Co-authorship network of co-authors of Leo F. Buckley

This figure shows the co-authorship network connecting the top 25 collaborators of Leo F. Buckley. A scholar is included among the top collaborators of Leo F. Buckley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo F. Buckley. Leo F. Buckley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Claggett, Brian, Victoria Arthur, Kunihiro Matsushita, et al.. (2025). Hepcidin, incident heart failure, and cardiac dysfunction in older adults: the ARIC study. European Journal of Preventive Cardiology. 32(11). 993–1000. 2 indexed citations
2.
Claggett, Brian, Scott D. Solomon, Pamela L. Lutsey, et al.. (2025). Differential Associations of Cardiac, Pulmonary, Arterial, and Muscle Physiological Parameters and Biomarkers With the Incidence of HFpEF and HFrEF. JACC Heart Failure. 13(8). 102483–102483. 1 indexed citations
3.
Buckley, Leo F. & Peter Libby. (2024). Colchicine’s Role in Cardiovascular Disease Management. Arteriosclerosis Thrombosis and Vascular Biology. 44(5). 1031–1041. 42 indexed citations
4.
Claggett, Brian, Victoria Arthur, Kunihiro Matsushita, et al.. (2024). Plasma Ferritin Levels, Incident Heart Failure, and Cardiac Structure and Function. JACC Heart Failure. 12(3). 539–548. 2 indexed citations
5.
Jia, Xiaoming, Leo F. Buckley, Mahmoud Al Rifai, et al.. (2023). Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. European Journal of Preventive Cardiology. 30(16). 1731–1740. 37 indexed citations
6.
Buckley, Leo F., Ali Agha, Brian Claggett, et al.. (2023). MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study. Circulation Heart Failure. 16(11). e010849–e010849. 12 indexed citations
7.
Jia, Xiaoming, Leo F. Buckley, Mahmoud Al Rifai, et al.. (2022). Abstract 11125: Association of Interleukin-6 and Interleukin-18 With Global Cardiovascular Disease in Older Adults. Circulation. 146(Suppl_1). 1 indexed citations
8.
Buckley, Leo F., William L. Baker, Benjamín Van Tassell, et al.. (2022). Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events. Hypertension. 80(2). 305–313. 24 indexed citations
9.
Wohlford, George F., Leo F. Buckley, Dinesh Kadariya, et al.. (2021). A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers. PLoS ONE. 16(5). e0247357–e0247357. 10 indexed citations
10.
Agha, Ali, Aliza Hussain, Carol Sun, et al.. (2021). THE PROGNOSTIC ROLE OF MATRIX METALLOPROTEINASE 7 (MMP-7) AMONG OLDER ADULTS: ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY. Journal of the American College of Cardiology. 77(18). 1635–1635. 1 indexed citations
11.
Fanikos, John, Leo F. Buckley, Umberto Campia, et al.. (2021). Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis. Blood Advances. 5(23). 5283–5289. 1 indexed citations
12.
Sumarsono, Andrew, Leo F. Buckley, Rishi K. Wadhera, et al.. (2020). Medicaid Expansion and Utilization of Antihyperglycemic Therapies. Diabetes Care. 43(11). 2684–2690. 15 indexed citations
13.
Buckley, Leo F., Judy W.M. Cheng, & Akshay S. Desai. (2020). Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2. Journal of Cardiovascular Pharmacology. 75(6). 526–529. 14 indexed citations
14.
Canada, Justin M., Cory R. Trankle, Salvatore Carbone, et al.. (2019). Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors. The American Journal of Cardiology. 125(6). 988–996. 17 indexed citations
15.
Wezenbeek, Jessie van, Justin M. Canada, Salvatore Carbone, et al.. (2019). Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions. The American Journal of Cardiology. 125(1). 76–81. 10 indexed citations
16.
Dixon, Dave L., et al.. (2018). Abstract 14190: Longer Time in Therapeutic Blood Pressure Range Protects Against Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hypertension: A Post-Hoc Analysis of SPRINT. Circulation. 1 indexed citations
17.
Buckley, Leo F., Dave L. Dixon, George F. Wohlford, et al.. (2018). Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow‐up: A subgroup analysis of high‐risk ACCORDION trial participants. Diabetes Obesity and Metabolism. 20(6). 1499–1502. 29 indexed citations
18.
Tassell, Benjamín Van, Justin M. Canada, Leo F. Buckley, et al.. (2017). Abstract 17709: Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction: The Diastolic Heart Failure Anakinra Response Trial 2 (DHART2). Circulation. 3 indexed citations
19.
Tassell, Benjamín W. Van, Nayef Abouzaki, Salvatore Carbone, et al.. (2016). Interleukin-1 Blockade in Acute Decompensated Heart Failure. Journal of Cardiovascular Pharmacology. 67(6). 544–551. 109 indexed citations
20.
Dixon, Dave L., Cory R. Trankle, Leo F. Buckley, et al.. (2016). A review of PCSK9 inhibition and its effects beyond LDL receptors. Journal of clinical lipidology. 10(5). 1073–1080. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026